Rheumatoid arthritis (RA) is a common disorder that affects the joints. RA is a systemic disease associated with relatively frequent and variable pleuropulmonary manifestations. This article reviews the common and potentially serious thoracic sequelae in terms of pleural disease, pulmonary nodules, airways disorders, and interstitial disease, as well as pulmonary side effects of antirheumatic medication. An imaging-guided approach to classification of RA-associated lung disease is outlined and the comparative values of different imaging modalities are discussed. An appreciation of current knowledge of epidemiology, pathological correlation, and prognostic implications of different RA-associated lung disease is provided. We highlight importance of considering pertinent differential diagnoses to avoid misdiagnosis, and outline common pitfalls in dealing with pleuropulmonary rheumatoid disease.
INTRODUCTION
Rheumatoid arthritis (RA) is a common inflammatory joint disease (~1% prevalence). The disease is more common in women; however, thoracic manifestations (2-54%) occur more commonly in males (5 : 1). The first clinical report of pulmonary disease occurring in RA was published by Ellman and Ball in 1948. [1] Pleuropulmonary involvement occurs after the onset of joint disease in 85% of cases and in patients with high serum rheumatoid factor titers and eosinophilia. In a large autopsy study, Tyoshina et al reported that lung involvement was second to infection (18% vs 27%) as the most common cause of death. [2] This article outlines the imaging features of the pleuropulmonary manifestations of RA, highlighting useful diagnostic features and common pitfalls.
Pleural disease
Postmortem studies show pleuropulmonary manifestation in 40 to 75% of cases. [2] Pleural disease is associated with subcutaneous nodules, interstitial lung disease (ILD), and pericarditis, often in middle-aged men with high rheumatoid titers. [3] 
Pleuritis (effusion +/-pleural thickening)
Effusions are seen in 3 to 5% of patients and usually occur during periods of active arthritis. [4] They are usually small, unilateral (L>R), and asymptomatic, with mild pain in 20 to 28% of patients.
They often resolve in a few weeks, but in some cases, may be persistent and recurrent. In various studies, almost all RA patients with pleural effusion were over 35 years, 80% were male, and approximately 80% had rheumatoid nodules. [4] A high prevalence of HLA-B8 and HLA-Dw3 genes is seen in patients with effusion.
Chest radiography remains the initial examination of choice [ Figure 1a ]. Small effusions may be detected using lateral decubitus radiograph. Ultrasound [ Figure 1b ] is useful in the detection of pleural fluid and focal pleural thickening and in identification of the best site for pleural thoracocentesis and biopsy. CT imaging may detect a small amount of pleural fluid (sickle-shaped opacity), identify loculated collections (lenticular or rounded opacities), and diagnose underlying lung pathology and extrapleural diseases. MRI and/or nuclear medicine scans are not routinely used.
Pyo/pneumothorax and bronchopleural fistula
Pneumothorax [ Figure 2 ] and empyema are unusual findings [3] in RA patients and may be secondary to cavitation of a necrobiotic nodule. A spontaneous sterile empyema may develop during active RA [ Figure 3 ]. Empyema appears on CT as lenticular opacity that causes compression of the surrounding lung. The "split-pleural" sign and thickening of the pleural layer are typical for the organizing phase of infective empyema. Bronchopleural fistula represents an even more unusual thoracic manifestation of RA, though case reports have been documented.
Pulmonary nodules
Rheumatoid nodules are more common in men, and usually occur in smokers with concomitant subcutaneous nodules and high titers of RF2. Nodules are well-circumscribed, located in lung, pleura, or pericardium and are histologically characterized by a central zone of eosinophilic fibrinoid necrosis surrounded by palisading fibroblasts. Nodules are identified in less than 1% of all chest radiographs [ Figure 4 ] but have been identified in up to 33% of biopsy specimen series. They are frequently subpleural, usually multiple, and range from a few millimeters to several centimeters in diameter [ Figure 5 ]. Cavitation [ Figures 6 and 7 ] is reported to occur in approximately 50% and calcification is rare.
Radiologically, rheumatoid nodules are nonspecific and pertinent differential diagnoses include malignancy, infection, and vasculitides. Regression with time or during treatment (with steroids) may be helpful in the diagnosis (initial interval surveillance), as RA nodules usually run a benign course. They may demonstrate uptake on FDG-PET, but this is not useful in terms of distinguishing between rheumatoid nodules and malignant lesions. Caplan's syndrome Caplan described the association of RA with pulmonary nodules and pneumoconiosis in 1953. [5] Peripheral, welldefined nodules often appear quickly in crops of new subcutaneous nodules at times of increased RA activity [ Figures 8 and 9 ]. Biopsy reveals inorganic dust within the necrotic nodule. These pulmonary nodules are usually asymptomatic and do not require treatment unless they rupture into the pleural space. This occurs in 2 to 6% of men affected by pneumoconioses.
Airway and interstitial disease
In many studies, a strong association between RA and disease of the airways as identified on pulmonary function tests [3] has been well documented. Geddes et al demonstrated that patients with a normal chest x-ray had airflow obstruction. [6] Bronchiectasis (cylindrical type) has been demonstrated in several cases and may be isolated or secondary to interstitial disease (traction bronchiectasis). The commonest radiographic appearance is of basal linear markings and focal infiltrates. On CT, bronchiectasis and brochiolectasis have been demonstrated in 30% of unselected patients. [3] On high-resolution CT (HRCT), a "tree-in-bud" appearance may reflect disease of the small airways.
Obliterative bronchiolitis [ Figure 10 ] is rare, tending to occur in women with well-established RA. Patients present with a dry cough and rapidly progressive dyspnea. This manifestation carries a poor prognosis. Chest radiographs may be normal. HRCT demonstrates a geometric, mosaic attenuation pattern. Expiratory scans confirm air trapping. Bronchocentric granulomatosis is even rarer.
Cricoarytenoid arthritis has been reported in 20 to 66% of RA patients. [7] On CT, between 54 and 72% (fewer in symptomatic) cases are identified. It is more common in female patients and CT may show cricoarytenoid erosion, luxation, and abnormal position of the true vocal cords.
ILD is associated with RA, radiographic abnormalities occur in 1 to 6%, and histological changes in 80%. The appearances on chest radiograph are of idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis). HRCT demonstrates ILD patterns. Diffuse interstitial pulmonary amyloidosis may mimic RA and should be considered in the differential diagnosis. Tanaka et al (2004) evaluated CT finding in RA and categorized findings according to pathologic features and compared their results with previous studies (summarized in Table 1 ). [8] Subsequent to the American Thoracic Society and European Respiratory Society consensus classification, RA may be seen to be associated with three main types of CT patterns: Usual interstitial pneumonia (UIP) [ Figure 11 ], non-specific interstitial pneumonia (NSIP) [ Figure 12 ], and organizing pneumonia [ Figure 13 ]. UIP and NSIP have significant overlap, demonstrating groundglass opacification and reticulation, and honeycombing has been seen in more than half of NSIP cases in recent studies. [8] 
Drug-induced lung disease
Drug-induced lung disease from disease-modifying antirheumatic drugs, with no pathognomonic features, is difficult to diagnose. Methotrexate may cause acute interstitial pneumonitis in 1 to 5% of patients, and can [8] be an unpredictable and life-threatening side effect of therapy. [9] Presentation is often subacute, with progressive cough, dyspnea, and fever. In a small number of patients, there may be rapid progression to respiratory failure. CXR demonstrates diffuse, bilateral, usually basal interstitial or alveolar infiltrates. [3] Lymphadenopathy and pleural effusions may suggest the diagnosis; HRCT shows an NSIP pattern [ Figure 14 ]. Methotrexate can also give rise to diffuse alveolar damage [ Figure 15 ] and various other pleuropulmonary disorders.
The numerous drugs/agents used to treat RA can give rise to a host of lung disease [ Figure 16 ]; the typical patterns are given in Table 2 .
CONCLUSIONS
Respiratory manifestations of RA encompass a multitude of radiological features and awareness of the entire spectrum is crucial. The term "rheumatoid lung" is an increasingly obsolete term that does not allow the clinician to appreciate the variety of presentations. In a minority of patients, pleuropulmonary manifestations may be the presenting feature of the disease. the most appropriate imaging modalities; this is usually achieved through first-line use of chest radiography combined with HRCT to fully characterize lung pathology. The roles of MRI and nuclear medicine are poorly defined and limited at present.
